A Study of TAK-279 in Adult Participants With Generalized Pustular Psoriasis or Erythrodermic Psoriasis
Phase
3Span
106 weeksSponsor
TakedaKisarazu, Chiba
Recruiting
A Study of Tirzepatide (LY3298176) Compared With Placebo in Adults With Type 1 Diabetes and Obesity or Overweight
Phase
3Span
110 weeksSponsor
Eli Lilly and CompanyKisarazu, Chiba
Recruiting
A Study of Lebrikizumab (LY3650150) in Adult Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP)
Phase
3Span
148 weeksSponsor
Eli Lilly and CompanyKisarazu, Chiba
Recruiting
1-3 of 3